Wellington Management Group LLP 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-08-05 1:44 pm Purchase |
2025-07-31 | 13G | Apogee Therapeutics, Inc. APGE |
Wellington Management Group LLP | 4,885,146 10.600% |
1,079,436 (+28.36%) |
Filing |
| 2025-08-05 1:35 pm Sale |
2025-06-30 | 13G | Apogee Therapeutics, Inc. APGE |
Wellington Management Group LLP | 3,805,710 8.300% |
-1,680,044 (-30.63%) |
Filing |
| 2025-05-12 10:44 am Purchase |
2025-03-31 | 13G | Apogee Therapeutics, Inc. APGE |
Wellington Management Group LLP | 5,485,754 11.900% |
671,354 (+13.94%) |
Filing |
| 2024-10-04 10:05 am Purchase |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
Wellington Management Group LLP | 4,814,400 10.700% |
4,814,400 (New Position) |
Filing |